| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
1 Korean DNA Repair Research Center, Departments of 2 Pharmacology, 3 Obstetrics and Gynecology, and 4 Anatomy, Chosun University School of Medicine, Gwangju, South Korea; 5 Department of Dermatology, University of Colorado Health Sciences Center, Denver, Colorado; 6 Department of Herbal Pharmaceutical Development, Korea Institute of Oriental Medicine, Daejeon, South Korea; 7 Department of Biochemistry, College of Medicine, Cheju National University, Jeju-do, South Korea; 8 Department of Anatomy, College of Medicine, Seonam University, Jeollabuk-Do, South Korea; and 9 Department of Pharmacology, School of Medicine, Seoul National University, Seoul, South Korea
Requests for reprints: Ho Jin You, Korean DNA Repair Research Center, Bio Engineering BD 2F, Department of Pharmacology, Chosun University School of Medicine, 375 Seosuk-Dong, Gwangju 501-759, Republic of Korea. Phone: 82-62-230-6337; Fax: 82-62-230-6586. E-mail: hjyou{at}chosun.ac.kr
Human 8-oxoguanine DNA glycosylase (hOGG1) is the main defense enzyme against mutagenic effects of cellular 7,8-dihydro-8-oxoguanine. In this study, we investigated the biological role of hOGG1 in DNA damage–related apoptosis induced by hydrogen peroxide (H2O2)–derived oxidative stress. The down-regulated expression of hOGG1 by its small interfering RNA prominently triggers the H2O2-induced apoptosis in human fibroblasts GM00637 and human lung carcinoma H1299 cells via the p53-mediated apoptotic pathway. However, the apoptotic responses were specifically inhibited by hOGG1 overexpression. The p53–small interfering RNA transfection into the hOGG1-deficient GM00637 markedly inhibited the H2O2-induced activation of p53-downstream target proteins such as p21, Noxa, and caspase-3/7, which eventually resulted in the increased cell viability. Although the cell viability of hOGG1-knockdown H1299 p53 null cells was similar to that of the hOGG1 wild-type H1299, after the overexpression of p53 the hOGG1-knockdown H1299 showed the significantly decreased cell viability compared with that of the hOGG1 wild-type H1299 at the same experimental condition. Moreover, the array comparative genome hybridization analyses revealed that the hOGG1-deficient GM00637 showed more significant changes in the copy number of large regions of their chromosomes in response to H2O2 treatment. Therefore, we suggest that although p53 is a major modulator of apoptosis, hOGG1 also plays a pivotal role in protecting cells against the H2O2-induced apoptosis at the upstream of the p53-dependent pathway to confer a survival advantage to human fibroblasts and human lung carcinomas through maintaining their genomic stability. (Mol Cancer Res 2007;5(10):1083–98)
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Cell Growth & Differentiation |